CAR- T and mobile gene therapies are actually as well expensive

.Nature Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing as well as innovation transactions may provide cell gene therapies at an economical expense to people around the world.